JP2013544089A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544089A5
JP2013544089A5 JP2013537286A JP2013537286A JP2013544089A5 JP 2013544089 A5 JP2013544089 A5 JP 2013544089A5 JP 2013537286 A JP2013537286 A JP 2013537286A JP 2013537286 A JP2013537286 A JP 2013537286A JP 2013544089 A5 JP2013544089 A5 JP 2013544089A5
Authority
JP
Japan
Prior art keywords
krtap4
group
expression level
tfpi2
mmp1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013537286A
Other languages
English (en)
Japanese (ja)
Other versions
JP6021021B2 (ja
JP2013544089A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2011/006203 external-priority patent/WO2012060109A1/en
Publication of JP2013544089A publication Critical patent/JP2013544089A/ja
Publication of JP2013544089A5 publication Critical patent/JP2013544089A5/ja
Application granted granted Critical
Publication of JP6021021B2 publication Critical patent/JP6021021B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013537286A 2010-11-05 2011-11-07 多発性嚢胞腎の検査方法および治療剤のスクリーニング方法 Active JP6021021B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41075710P 2010-11-05 2010-11-05
US61/410,757 2010-11-05
US201161530269P 2011-09-01 2011-09-01
US61/530,269 2011-09-01
PCT/JP2011/006203 WO2012060109A1 (en) 2010-11-05 2011-11-07 Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease

Publications (3)

Publication Number Publication Date
JP2013544089A JP2013544089A (ja) 2013-12-12
JP2013544089A5 true JP2013544089A5 (https=) 2014-12-25
JP6021021B2 JP6021021B2 (ja) 2016-11-02

Family

ID=46024234

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013537286A Active JP6021021B2 (ja) 2010-11-05 2011-11-07 多発性嚢胞腎の検査方法および治療剤のスクリーニング方法

Country Status (4)

Country Link
US (1) US20130225443A1 (https=)
EP (1) EP2635707B1 (https=)
JP (1) JP6021021B2 (https=)
WO (1) WO2012060109A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CA2648385C (en) 2006-04-04 2020-09-01 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
JP5678045B2 (ja) 2009-06-08 2015-02-25 シンギュレックス・インコーポレイテッド 高感度バイオマーカーパネル
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
ES2983924T3 (es) 2015-03-27 2024-10-28 Immatics Biotechnologies Gmbh Péptidos novedosos y combinación de péptidos para usarse en inmunoterapia contra diferentes tumores
CN104771630A (zh) * 2015-04-07 2015-07-15 陆开云 一种治疗小儿疝气的药物
JP6621195B2 (ja) * 2015-07-17 2019-12-18 国立大学法人京都大学 多発性嚢胞腎の検査方法および治療剤のスクリーニング方法
EA201891170A1 (ru) 2015-11-18 2018-11-30 Джензим Корпорейшн Биомаркер поликистозной болезни почек и варианты его применения
CA3082528A1 (en) 2017-11-17 2019-05-23 Osaka University Cell population of cd31-positive, cd45-negative, cd200-positive mammalian cells and use thereof
KR102288447B1 (ko) * 2018-12-28 2021-08-10 서울대학교산학협력단 Ctgf 검출용 제제를 포함하는 다낭신의 진단용 조성물 및 이의 이용
KR102885974B1 (ko) * 2019-11-22 2025-11-13 서울대학교산학협력단 Metrnl 검출용 제제를 포함하는 다낭신의 진단용 조성물 및 이의 이용
KR102859441B1 (ko) * 2019-11-22 2025-09-12 서울대학교산학협력단 Opn 검출용 제제를 포함하는, 다낭신의 진단용 조성물 및 이의 이용
EP4185693B1 (en) * 2020-07-23 2026-02-11 Johann Wolfgang Goethe-Universität Frankfurt Combinatorial inhibition of transcription factors for treatment of heart failure
CN112798789A (zh) * 2020-12-08 2021-05-14 彭志勇 一种用于重症患者aki早期诊断的方法
CN112877275B (zh) * 2021-02-04 2023-03-31 中国农业科学院兰州兽医研究所 Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
US20250263700A1 (en) * 2022-05-26 2025-08-21 Yale University Method of treating, ameliorating and/or preventing polycystic kidney disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US20020103360A1 (en) 1998-09-01 2002-08-01 Yang Pan Novel protein related to melanoma-inhibiting protein and uses thereof
US7553644B2 (en) 2000-07-13 2009-06-30 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease
US6916619B2 (en) 2001-10-12 2005-07-12 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
CA2461106C (en) * 2003-04-11 2015-02-24 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
CN101233227A (zh) 2005-02-03 2008-07-30 国立大学法人冈山大学 由胚胎干细胞向肝细胞的分化诱导方法和由该方法诱导的肝细胞
JP2006239169A (ja) 2005-03-03 2006-09-14 Miyako Takagi 胚性幹細胞から分化誘導した腸管様細胞塊における壁内神経系の形成方法
JP5119430B2 (ja) * 2005-04-08 2013-01-16 国立大学法人名古屋大学 多発性嚢胞腎疾患関連遺伝子及びその利用
WO2006118566A2 (en) * 2005-04-29 2006-11-09 Mayo Foundation For Medical Education And Research Assessing brain aneurysms
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
EP1999253B1 (en) 2006-03-02 2019-05-22 Viacyte, Inc. Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production
JP2010075631A (ja) 2008-09-29 2010-04-08 Japan Science & Technology Agency 未分化細胞から肝臓を分化誘導する方法
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture

Similar Documents

Publication Publication Date Title
JP2013544089A5 (https=)
Selvakumar et al. MicroRNA-510-3p regulated vascular dysfunction in preeclampsia by targeting vascular endothelial growth factor A (VEGFA) and its signaling axis
Shaker et al. Diagnostic and prognostic role of serum miR‐20b, miR‐17‐3p, HOTAIR, and MALAT1 in diabetic retinopathy
CN111065748B (zh) 非酒精性脂肪性肝病、非酒精性脂肪性肝炎和/或肝纤维化的非侵入性诊断
Bye et al. Circulating microRNAs predict future fatal myocardial infarction in healthy individuals–The HUNT study
JP2020531023A (ja) 非アルコール性脂肪性肝疾患、非アルコール性脂肪性肝炎、及び／又は肝線維症の非侵襲的診断
Cao et al. MicroRNA as novel biomarkers and therapeutic targets in diabetic kidney disease: an update
Li et al. HIF1A and VEGF regulate each other by competing endogenous RNA mechanism and involve in the pathogenesis of peritoneal fibrosis
Chen et al. Recent advances of MicroRNAs, long non-coding RNAs, and circular RNAs in preeclampsia
KR102341336B1 (ko) 만성간질환의 예후 예측용 바이오마커 조성물
KR102105016B1 (ko) miR-485-3p를 이용한 알츠하이머병 진단 방법
US20210214793A1 (en) Blood biomarkers of stroke
Ding et al. A polymorphism rs3746444 within the pre‐miR‐499 alters the maturation of miR‐499‐5p and its antiapoptotic function
Zhang et al. Expression of miR-98 in myocarditis and its influence on transcription of the FAS/FASL gene pair
Yin et al. Effect of lncRNA‐ATB/miR‐651‐3p/Yin Yang 1 pathway on trophoblast‐endothelial cell interaction networks
Sun et al. Downregulation of microRNA‐101‐3p participates in systemic lupus erythematosus progression via negatively regulating HDAC9
CN105063194B (zh) 一种帕金森的诊断标志物及其应用
KR20200043322A (ko) miR-485-3p를 이용한 알츠하이머병 진단 방법
Mohammed et al. Long non-coding RNA NBAT1, TUG1, miRNA-335, and miRNA-21 as potential biomarkers for acute ischemic stroke and their possible correlation to thyroid hormones
KR101315570B1 (ko) 간암 진단 마커 및 치료제로서의 ｎｌｋ
Wang et al. Systemic lupus erythematosus-specific CD14+ IFITM3+ monocyte: Implications for disease activity and progression
Olatunde et al. Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments
ES3058210T3 (en) Circulating serum microrna biomarkers and methods for alzheimer's disease diagnosis
Wang et al. Platelet microRNA-15b protects against high platelet reactivity in patients undergoing percutaneous coronary intervention through Bcl-2-mediated platelet apoptosis
KR102358385B1 (ko) 대장암 및 직장암의 예방, 진단 또는 치료를 위한 ｖｌｄｌｒ의 용도